Open ahwagner opened 5 years ago
How about immunoconjugates, novel drug delivery systems, CAR-T cells
Ultimately, do we want to cover the scope of treatments (any modality)
FWIW immunotherapy is not a "treatment" in the sense that it does not have a direct effect on the cancer
Our recommendations will require handling of non-drug (e.g. radiation) therapy terms.